Iron bioresorbable scaffold achieves noninferior angiographic and clinical outcomes versus drug eluting stent at 2 years in ...
LONDON, England—A device designed to deter accruing risks of stent-related adverse events has proven itself once again in a noninferiority trial against a workhorse drug-eluting stent, results from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results